Market Fallers: AstraZeneca, Carnival, Ferguson PLC, Imperial Brands PLC

Ferguson PLC
[shareaholic app="share_buttons" id_name="post_below_content"]

Shares in AstraZeneca plc ticker code: LON:AZN has declined -1.42% or -103 points in today’s trading session so far. Investors aired on the negative side during the session. Range high for the period has seen 7295 while the low for the session was 7152. The total volume of shares exchanged so far has reached 458,945 while the average shares exchanged is 2,202,215. A 52 week share price high is 7479 which comes in at 166 points difference from the previous close and the 52 week low at 5312 a difference of some 2001 points. AstraZeneca plc has a 20 day moving average of 7321.1 and now a 50 day MA at 6844.27. Market capitalisation for the company is £94,573.17m at the time of this report. All share prices mentioned for this stock are traded in GBX. Mcap is measured in GBP. This article was written with the last trade for AstraZeneca plc being recorded at Tuesday, August 27, 2019 at 12:07:04 PM GMT with the stock price trading at 7210 GBX.

The stock price for Carnival plc with ticker code: LON:CCL has stepped down -1.43% or -49 points during today’s session so far. Sellers did not seem confident during the trading session. The periods high figure was 3389 while the low for the session was 3332. Volume total for shares traded at this point reached 242,738 with the daily average number around 806,305. The 52 week high for the shares is 5030 amounting to 1596 points different to the previous business close and a 52 week low sitting at 3332 making a difference of 102 points. Carnival plc now has a 20 SMA at 3626.96 with a 50 day simple moving average now at 3617.47. Market capitalisation is now £23,728.52m at the time of this report. All share prices mentioned for this stock are traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Carnival plc being recorded at Tuesday, August 27, 2019 at 12:07:02 PM GMT with the stock price trading at 3385 GBX.

The trading price for Ferguson PLC with ticker code: LON:FERG has slid -2.31% or -138 points during today’s session so far. Traders have not remained optimistic during this period. The high for the period has reached 5854 and a low of 5778. The total volume of shares exchanged so far has reached 160,394 with the daily average at 612,759. A 52 week high for the stock is 6601 around 617 points in difference to the previous days close of business and a 52 week low sitting at 4594 a difference of some 1390 points. Ferguson PLC now has a 20 SMA of 6106.95 and the 50 day simple moving average now at 5949.92. The current market cap is £13,407.78m at the time of this report. The stock is traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Ferguson PLC being recorded at Tuesday, August 27, 2019 at 12:06:17 PM GMT with the stock price trading at 5846 GBX.

Shares in Imperial Brands PLC with ticker code: LON:IMB has moved down -1.8% or -37 points during today’s session so far. Sellers aired on the negative side throughout the trading session. The periods high figure was 2056.5 while the low for the session was 1987.2. The volume total for shares traded up to this point was 557,462 whilst the daily average number of shares exchanged is just 2,145,923. The 52 week high for the shares is 2844.5 around 789.5 points in difference to the previous days close of business and a 52 week low sitting at 1771 is a variance of 284 points. Imperial Brands PLC has a 20 SMA of 2121.15 and now its 50 day MA at 2058.98. The market capitalisation currently stands at £19,245.34m at the time of this report. The stock is traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Imperial Brands PLC being recorded at Tuesday, August 27, 2019 at 12:06:19 PM GMT with the stock price trading at 2018 GBX.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
    AstraZeneca's Imfinzi receives FDA approval for limited-stage small cell lung cancer, marking a significant breakthrough in extending patient survival.
    Imperial Brands PLC reports a robust 2024 with 4.6% revenue growth, significant gains in market share, and a 10.9% increase in adjusted earnings per share.
    AstraZeneca Plc commits $3.5 billion to boost US research and manufacturing by 2026, creating jobs and expanding its innovation footprint.

      Search

      Search